Screener
Regenxbio RGNX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 236,157 | 281,281 |
| Marketable securities | — | 10,785 |
| Accounts receivable | 435 | 2,312 |
| Property and equipment, net | 98,452 | 104,855 |
| Operating lease right-of-use assets | 43,867 | 47,156 |
| Restricted cash | 1,805 | 2,030 |
| Other assets | 5,902 | 4,613 |
| Total assets | $386,618 | $453,032 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's PP&E (net)?
- Regenxbio (RGNX) reported PP&E (net) of $98.45M in Q2 2026.
- How has Regenxbio's PP&E (net) changed year-over-year?
- Regenxbio's PP&E (net) decreased by 11.3% year-over-year, from $111.02M to $98.45M.
- What is the long-term trend for Regenxbio's PP&E (net)?
- Over 5 years (2020 to 2025), Regenxbio's PP&E (net) has grown at a 13.2% compound annual growth rate (CAGR), from $56.47M to $104.86M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Regenxbio's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude